GlassScriptPhysician profile
John T Chow
NPI 1851365985
$2,951.62
in general payments reported to CMS, 2019-2025
44 companies · $415 in 2025
The $415 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $339 · 2020: $278 · 2021: $376 · 2022: $393 · 2023: $576 · 2024: $574 · 2025: $415.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,505 · Gift: $59.40.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,505.12 |
| Gift | $59.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $285.52 | 2021-2025 | Minimed 780g, Intellis Adaptivestim, Inceptiv |
| Amgen INC. | $210.12 | 2019-2025 | Tepezza, Repatha |
| Insulet Corporation | $208.92 | 2019-2025 | Omnipod |
| Alexion Pharmaceuticals, INC. | $160.62 | 2019-2024 | Strensiq |
| Dexcom, INC. | $156.97 | 2019-2024 | Dexcom G6 Transmitter |
| Antares Pharma, INC. | $148.96 | 2019-2025 | Xyosted |
| Abbott Laboratories | $142.23 | 2022-2025 | Freestyle Libre 3 |
| Mannkind Corporation | $118.16 | 2023-2025 | Afrezza |
| Beta Bionics, INC. | $116.05 | 2023-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Esperion Therapeutics, INC. | $88.29 | 2024-2025 | Nexletol |
| Bayer Healthcare Pharmaceuticals INC. | $80.05 | 2021-2025 | |
| Recordati_rare_diseases_inc. | $80.03 | 2021-2025 | Isturisa |
| Medtronic Minimed, INC. | $78.12 | 2019-2020 | |
| Novo Nordisk INC | $74.09 | 2019-2022 | |
| Cequr Corporation | $71.15 | 2022-2025 | Cequr Simplicity |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Chow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.